Diisopropylethylamine → HCID 67353598, Verbindung

HRID 1676603

Reaktionsgleichung

Reaktionsgleichung von HRID 1676603
[CH2:1]([O:8][C:9]([N:11]1[CH2:16][CH2:15][C@H:14]([OH:17])[C@@H:13]([NH2:18])[CH2:12]1)=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.[CH:19]1([N:24]2[CH2:30][C:29]([F:32])([F:31])[C:28](=[O:33])[N:27]([CH3:34])[C:26]3[CH:35]=[N:36][C:37]([NH:39][C:40]4[CH:48]=[CH:47][C:43]([C:44](O)=[O:45])=[CH:42][C:41]=4[O:49][CH3:50])=[N:38][C:25]2=3)[CH2:23][CH2:22][CH2:21][CH2:20]1.F[P-](F)(F)(F)(F)F.[CH3:58]N(C(N(C)C)=[N+]1C2C=CC=CC=2[N+]([O-])=N1)C.C(N(C(C)C)CC)(C)C>O.CN(C)C=O>[CH2:1]([O:8][C:9]([N:11]1[CH2:16][CH2:15][CH:14]([O:17][CH3:58])[CH:13]([NH:18][C:44](=[O:45])[C:43]2[CH:47]=[CH:48][C:40]([NH:39][C:37]3[N:36]=[CH:35][C:26]4[N:27]([CH3:34])[C:28](=[O:33])[C:29]([F:31])([F:32])[CH2:30][N:24]([CH:19]5[CH2:20][CH2:21][CH2:22][CH2:23]5)[C:25]=4[N:38]=3)=[C:41]([O:49][CH3:50])[CH:42]=2)[CH2:12]1)=[O:10])[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1

Komponenten

7

Versuchsvorschrift

A mixture of 0.078 g (0.30 mmole) of (rac)-(3S,4S)-3-amino-4-hydroxy-piperidine-1-carboxylic acid benzyl ester, 0.113 g (0.25 mmole) of 4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-benzoic acid (I-22), 0.1138 g (0.30 mmole) 1-[bis(dimethylamino)methylene]-1H-benzotriazolium-3-oxide hexafluorophosphate, 0.0776 g (0.60 mmole) of diisopropylethylamine and 2 mL of dimethylformamide was stirred at room temperature for 1 hour. The mixture was poured into 50 mL of water and extracted three times with 25 mL of ethyl acetate. The combined organic extracts were washed three times with 25 mL of water, once with 25 mL of saturated aqueous ammonium chloride solution, once with 25 mL of saturated aqueous sodium bicarbonate solution, once with 25 mL of brine and dried over anhydrous magnesium sulfate. The mixture was filtered and concentrated under reduced pressure. The residue was purified by silica gel chromatography, eluting with dichloromethane-methanol (96:4) to give 0.088 g of rac-(3S,4S)-3-[4-(9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxy-benzoylamino]-4-methoxy-piperidine-1-carboxylic acid benzyl ester (I-58) as a foam. Tritruration of the foam with diethyl ether gave a white solid.

Aufarbeitung

  1. extractionextracted three times with 25 mL of ethyl acetate
  2. washThe combined organic extracts were washed three times with 25 mL of water
  3. dry with materialonce with 25 mL of saturated aqueous ammonium chloride solution, once with 25 mL of saturated aqueous sodium bicarbonate solution, once with 25 mL of brine and dried over anhydrous magnesium sulfate
  4. filtrationThe mixture was filtered
  5. concentrationconcentrated under reduced pressure
  6. customThe residue was purified by silica gel chromatography
  7. washeluting with dichloromethane-methanol (96:4)

Quellen und Nachweise

ORD-Eintrag
ord-ff49f5a1199e451d8fe7efb8de37e6ee
Quelldatensatz
uspto-grants-2011_08
Patentnummer
US08003785B2

Verknüpfte Notizen

Wird geladen…